{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:07:38Z","timestamp":1789175258751,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015459","name":"Danish Cancer Society Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007606","name":"Aarhus Universitetshospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.radonc.2025.110954","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T11:47:48Z","timestamp":1748519268000},"page":"110954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis"],"prefix":"10.1016","volume":"210","author":[{"given":"M.","family":"Serban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Spampinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kirisits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.Y.","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-9567","authenticated-orcid":false,"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Mahantshetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Segedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bruheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-9642","authenticated-orcid":false,"given":"F.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7797-4696","authenticated-orcid":false,"given":"R.","family":"Bhavana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Der","family":"Steen Banasik E","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.Van","family":"Limbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.R.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LT.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nesvacil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kirchheiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"P\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tanderup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110954_b0005","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijrobp.2010.10.030","article-title":"International brachytherapy practice patterns: a survey of the gynecologic cancer intergroup (GCIG)","volume":"82","author":"Viswanathan","year":"2012","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110954_b0010","first-page":"131","article-title":"Is the tandem and ring applicator a suitable alternative to the high dose rate selectron tandem and ovoid applicator?","volume":"16","author":"Erickson","year":"2000","journal-title":"Journal of Brachytherapy International"},{"key":"10.1016\/j.radonc.2025.110954_b0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0958-3947(95)00019-S","article-title":"High dose rate (HDR) brachytherapy technique: For carcinoma of uterine cervix using nucletron applicators","volume":"20","author":"Nair","year":"1995","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2025.110954_b0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5114\/jcb.2015.51853","article-title":"Original paperShort-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary applicators","volume":"7","author":"Ma","year":"2015","journal-title":"Journal of Contemporary Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0025","doi-asserted-by":"crossref","unstructured":"Talcott WJ, Duckworth T, Wu SPP, Ishaq O, Walton RM, Osterman KS, et al. Spatial and Dosimetric Comparison of Tandem\/Ring Applicator Against Adjustable Tandem\/Ovoid and Tandem\/Split-Ring for Intracavitary Brachytherapy Treatment of Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 2017;99(2, Supplement):E312.","DOI":"10.1016\/j.ijrobp.2017.06.1348"},{"key":"10.1016\/j.radonc.2025.110954_b0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5114\/jcb.2017.70677","article-title":"Comparison of dose volume parameters evaluated using three forward planning \u2013 optimization techniques in cervical cancer brachytherapy involving two applicators","volume":"9","author":"Chakrabarti","year":"2017","journal-title":"Journal of Contemporary Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.brachy.2006.03.021","article-title":"Vaginal dose delivered by tandem and ovoid versus tandem and ring in cervical cancer","volume":"5","author":"Holloway","year":"2006","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0040","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.brachy.2010.02.073","article-title":"Case-Crossover Study of Tandem-Ovoid versus Tandem-Ring 3D-Based Brachytherapy in Locally Advanced Cervical Cancer","volume":"9","author":"Brown","year":"2010","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0045","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110954_b0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2014.01.032","article-title":"Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study","volume":"89","author":"Kirchheiner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.110954_b0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0060","doi-asserted-by":"crossref","unstructured":"R. P\u00f6tter CK, B. Erickson, C. Haie-Meder, E. Van Limbergen, J.C. Lindegaard, J. Rownd, K. Tanderup, B.R. Thomadsen. ICRU Report 89, Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. Journal of the ICRU. 2013;13(1-2):188.","DOI":"10.1093\/jicru_ndw042"},{"key":"10.1016\/j.radonc.2025.110954_b0065","doi-asserted-by":"crossref","unstructured":"K. Jensen NB, P\u00f6tter R, Spampinato S, Fokdal LU, Chargari C, Lindegaard JC, et al. Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study. International Journal of Radiation Oncology*Biology*Physics. 2021;109(3):688-700.","DOI":"10.1016\/j.ijrobp.2020.10.006"},{"key":"10.1016\/j.radonc.2025.110954_b0070","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semradonc.2020.05.008","article-title":"Evidence-Based Dose Planning Aims and Dose Prescription in Image-Guided Brachytherapy Combined With Radiochemotherapy in Locally Advanced Cervical Cancer","volume":"30","author":"Tanderup","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.brachy.2021.02.004","article-title":"Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity","volume":"20","author":"Serban","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijrobp.2021.09.055","article-title":"Severity and Persistency of Late Gastrointestinal Morbidity in Locally Advanced Cervical Cancer: Lessons Learned From EMBRACE-I and Implications for the Future","volume":"112","author":"Spampinato","year":"2022","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110954_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.radonc.2021.12.034","article-title":"Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study","volume":"168","author":"Westerveld","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2015.12.025","article-title":"Dose\u2013effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study","volume":"118","author":"Kirchheiner","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group\u2606 (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.brachy.2014.11.006","article-title":"Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position","volume":"14","author":"Nkiwane","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2019.12.011","article-title":"MRI-based contouring of functional sub-structures of the lower urinary tract in gynaecological radiotherapy","volume":"145","author":"Spampinato","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejmp.2019.01.017","article-title":"Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy","volume":"59","author":"Spampinato","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2025.110954_b0130","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.brachy.2021.03.019","article-title":"Characterization of combined intracavitary\/interstitial brachytherapy including oblique needles in locally advanced cervix cancer","volume":"20","author":"Serban","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tipsro.2018.10.001","article-title":"Implementation of state-of-the-art (chemo)radiation for advanced cervix cancer in the Netherlands: A quality improvement program","volume":"9","author":"De Leeuw","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0140","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.radonc.2009.08.014","article-title":"MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary\/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer","volume":"93","author":"J\u00fcrgenliemk-Schulz","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2009.10.011","volume":"94","author":"J\u00fcrgenliemk-Schulz","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2012.10.002","article-title":"Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: Comparison between tandem-ovoid applicator users","volume":"107","author":"Nomden","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0155","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.brachy.2020.08.011","article-title":"Initiatives for education, training, and dissemination of morbidity assessment and reporting in a multiinstitutional international context: Insights from the EMBRACE studies on cervical cancer","volume":"19","author":"Kirchheiner","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.radonc.2025.110954_b0160","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jjco\/hyt028","article-title":"Evaluation of Interobserver and Interscale Agreement in Assessing Late Bowel Toxicity after Pelvic Radiation in Patients with Carcinoma of the Cervix","volume":"43","author":"Chinnachamy","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.110954_b0165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ygyno.2022.06.019","article-title":"Clinical outcome of combined intracavitary \/ interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer","volume":"166","author":"Rogowski","year":"2022","journal-title":"Gynecol Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025044585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:27:05Z","timestamp":1789172825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025044585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"alternative-id":["S0167814025044585"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110954","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110954"}}